Ram. I still take my Vascepa ...however you and others here should be aware of the recent clinical guidance published on Healio / Cardiology
( my emphasis )
The biomarker analysis they refer to I think is the Dr Ridker paper . Capt was linking an in -vitro study I believe . Cardiologists IMHO prescribe mainly on Outcome data ....which is why any CV data extracted from MITIGATE will be important. MITIGATE is now 21 days past its clinical trial.gov end of study completion date .....and complete radio silence from both Kaiser and AMRN. Lets hope they drop data like AMRN did ....with the top line R-IT results . Kiwi